Biotinylated Mouse VEGF-D Protein, His,Avitag™

ユーザーレビュー
製品番号/仕様
価格
数量
VED-M82E4-25ug
$350.00
VED-M82E4-200ug
$1380.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Synonyms

    FIGF, VEGFD

  • Source

    Biotinylated Mouse VEGF-D Protein, His,Avitag (VED-M82E4) is expressed from human 293 cells (HEK293). It contains AA Phe 98 - Ser 206 (Accession # P97946).

    Predicted N-terminus: Phe 98

    Request for sequence
  • Molecular Characterization

    VEGF-D Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™).

    The protein has a calculated MW of 19.6 kDa. The protein migrates as 28-31 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Labeling

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • SDS-PAGE

    VEGF-D SDS-PAGE

    Biotinylated Mouse VEGF-D Protein, His,Avitag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • Bioactivity-ELISA

     VEGF-D ELISA

    Immobilized Mouse VEGF R3 Protein, Mouse IgG2a Fc Tag (Cat. No. FL4-M5251) at 5 μg/mL (100 μL/well) can bind Biotinylated Mouse VEGF-D Protein, His,Avitag (Cat. No. VED-M82E4) with a linear range of 10-78 ng/mL (QC tested).

    Protocol
  •  VEGF-D ELISA

    Immobilized Mouse VEGF R2 Protein, Mouse IgG2a Fc Tag (Cat. No. VE2-M5258) at 5 μg/mL (100 μL/well) can bind Biotinylated Mouse VEGF-D Protein, His,Avitag (Cat. No. VED-M82E4) with a linear range of 0.01-0.156 μg/mL (Routinely tested).

    Protocol
  •  VEGF-D ELISA

    Immobilized Mouse VEGF R1 Protein, Mouse IgG2a Fc Tag (Cat. No. VE1-M5256) at 5 μg/mL (100 μL/well) can bind Biotinylated Mouse VEGF-D Protein, His,Avitag (Cat. No. VED-M82E4) with a linear range of 0.039-1.25 μg/mL (Routinely tested).

    Protocol
  • Bioactivity-SPR

     VEGF-D SPR

    Mouse VEGF R3 Protein, Mouse IgG2a Fc Tag (Cat. No. FL4-M5251) captured on CM5 chip via anti-mouse antibodies surface can bind Biotinylated Mouse VEGF-D Protein, His,Avitag (Cat. No. VED-M82E4) with an affinity constant of 2.13 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol

ユーザーレビュー
コメントを投稿

バックグランド

Vascular endothelial growth factor D (VEGF-D) is also known as C-fos induced growth factor (FIGF), which belongs to the PDGF / VEGF growth factor family and is active in angiogenesis, lymphangiogenesis, and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. This secreted protein VEGF-D / FIGF undergoes a complex proteolytic maturation, generating multiple processed forms that bind and activate VEGFR-2 and VEGFR-3. The structure and function of this protein is similar to those of VEGFC. FIGF / VEGF-D is highly expressed in lung, heart, small intestine and fetal lung. FIGF / VEGF-D may function in the formation of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates VEGFR-2 (KDR / FLK1) and VEGFR-3 (FLT4) receptors.

最新の進展

 
医薬品開発の進捗
  • 英語名:

    Vascular endothelial growth factor D

  • カテゴリ:

  • 市販の医薬品数:

    0 詳細

  • 治験医薬品数:

    2 詳細

  • 最新の開発ステージ:

    Phase 2 Clinical

お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
  • 背景
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8